鲁文嘉，女，籍贯甘肃古浪，1995年10月生人，博士，讲师，毕业于华中农业大学，现就职于44118太阳成城集团。
研究方向：新型药物的开发与致病机制的探究及病原微生物毒力调控机制探究。并以第一作者身份发表论文3篇，参与文章发表18篇。
主要论著：
1. Lu W, Lu H, Wang C, Wang G, Dong W, Tan C. Effectors of the Type VI Secretion System Have the Potential to Be Modified into Antimicrobial Peptides. Microbiol Spectr. 2023, 11: e0030823
2. Lu W, Tan J, Lu H, Wang G, Dong W, Wang C, Li X, Tan C. Function of Rhs proteins in porcine extraintestinal pathogenic Escherichia coli PCN033. J Microbiol. 2021c, 59: 854-860
3. Lu H, Lu W, Zhu Y, Wang C, Shi L, Li X, Wu Z, Wang G, Dong W, Tan C, Liu M. Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe Streptococcus suis Infections. Antibiotics (Basel). 2020b, 10
4. Lu H, Wang C, Lu W, Li X, Wu Z, Wang G, Dong W, Tan C, Liu M. Apigenin and Ampicillin as Combined Strategy to Treat Severe Streptococcus suis Infection. Molecules. 2021b, 26
5. Lu H, Liu M, Lu W, Wang C, Wang G, Dong W, Wang X, Chen H, Tan C. Repurposing Ellipticine Hydrochloride to Combat Colistin-Resistant Extraintestinal Pathogenic (ExPEC). Front Microbiol. 2020a, 11: 806
6. Hu L, Wang C, Lu W, Lu H, Chen H, Tan C. BaeSR activates type VI secretion system expression in porcine extra-intestinal pathogenic Escherichia coli to enhance bacterial resistance to zinc stress. Microb Pathog. 2020, 147: 104357
